Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study

A. L. Moekotte, G. Malleo, S. van Roessel, M. Bonds, A. Halimi, L. Zarantonello, N. Napoli, S. B. Dreyer, U. F. Wellner, L. Bolm, V. K. Mavroeidis, S. Robinson, K. Khalil, D. Ferraro, M. C. Mortimer, S. Harris, B. Al-Sarireh, G. K. Fusai, K. J. Roberts, M. FontanaS. A. White, Z. Soonawalla, N. B. Jamieson, U. Boggi, A. Alseidi, A. Shablak, J. W. Wilmink, J. N. Primrose, R. Salvia, C. Bassi, M. G. Besselink, M. Abu Hilal*

*Corresponding author for this work

Fingerprint

Dive into the research topics of 'Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences